首页> 外国专利> Radioreceptor assay for benzodiazepines in saliva

Radioreceptor assay for benzodiazepines in saliva

机译:唾液中苯二氮卓类药物的放射受体测定

摘要

A radioreceptor assay for benzodiazepines in saliva which comprises measuring the diminution of attachment of a known quantity of radio labeled benzodiazepine to a receptor carrier in the presence of an unknown quantity of unlabeled benzodiazepine in a known amount of human saliva. Benzodiazepines are selected from the following oft-utilized drugs which are also representative types of benzodiazepine; namely, diazepam (Valium), chlordiazepoxide (Librium), nitrazepam (Benzalin), oxazepam (Serax), flurazepam (Dalmane), and clorazepate.PP Competitive receptors suitable for the present benzodiazepine radioreceptor assay are from fresh rat frontal cortex. Utilizable receptors are whole brain cortex, human cortex, and striatum.
机译:唾液中苯二氮卓类的放射性受体测定,包括在已知量的人类唾液中存在未知量的未标记苯二氮卓类的情况下,测量已知量的放射性标记的苯二氮卓类与受体载体的附着程度。苯二氮卓类药物选自下列常用药物,它们也是苯二氮卓类药物的代表类型;分别是地西m(Valium),氯二氮卓(Librium),硝西epa(Benzalin),奥沙西m(Serax),氟拉西m(Dalmane)和clorazepate。皮层。可利用的受体是全脑皮层,人类皮层和纹状体。

著录项

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号